Huprine Y
Acetylcholinesterase inhibitor
From Wikipedia, the free encyclopedia
Huprine Y is an anticholinesterase compound. According to research, it could potentially have usefulness in management of certain diseases such as Alzheimer's disease.[1][2]
| Names | |
|---|---|
| IUPAC name
7-chloro-15-methyl-10-azatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4(9),5,7,10,14-hexaen-3-amine | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
PubChem CID |
|
| |
| |
| Properties | |
| C17H17ClN2 | |
| Molar mass | 284.79 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Chemistry
Mechanism of action
As an anticholinesterase compound, its main mechanism of action is inhibition of the acetylcholine esterase enzyme, which hydrolyses acetylcholine.[6] In other words, huprine Y reduces the action of the AChE enzyme, resulting in elevated levels of acetylcholine. Like other similar compounds, it appears to have strong affinity when binding to the enzyme.[7][8]
